INTERVIEW | ChenGang, the founder and CEO of WeGene: The Application of whole genome sequencing is an inevitable trend of technological development
On September 9, 2019, DNBSEQ-T7, an ultra-high-throughput gene sequencer independently developed by MGI, was officially released for commercial use. Among them, WeGene is the first batch of customers of DNBSEQ-T7 sequencer. Recently, MGI invited Dr. Gang Chen, the founder and CEO of WeGene, to conduct an interview. Dr. Gang Gang, the founder and CEO of WeGene The data of whole genome sequencing is very valuable, which can better meet the detection of more complex mutations. In the applic...
More2019-12-12